Parabilis Medicines Inc. , a clinical-stage cancer drug developer, raised nearly $745 million in an upsized US initial public offering that priced above its marketed range, and a private placement.

Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-06-10/drugmaker-parabilis-raises-745-million-in-us-ipo-placement)

Sponsored